Financial Times:

Demis Hassabis, chief of DeepMind spinout Isomorphic Labs, believes the company would halve drug discovery times after inking deals with Eli Lilly and Novartis  —  Chief of Google's AI unit and Isomorphic Labs spells out targets following $3bn Eli Lilly-Novartis partnerships

Financial Times:

Demis Hassabis, chief of DeepMind spinout Isomorphic Labs, believes the company would halve drug discovery times after inking deals with Eli Lilly and Novartis  —  Chief of Google's AI unit and Isomorphic Labs spells out targets following $3bn Eli Lilly-Novartis partnerships

Source: TechMeme
Source Link: http://www.techmeme.com/240110/p7#a240110p7